November 8, 2024 03:09 PM EST
Pharma
FDA+
Manufacturing

FDA records re­quest lands Chi­nese API man­u­fac­tur­er on blocked im­port list

Zachary Brennan

Senior Editor

The FDA this week post­ed an un­ti­tled let­ter sent Oct. 17 to Chi­na-based ac­tive phar­ma­ceu­ti­cal in­gre­di­ent (API) man­u­fac­tur­er Shan­dong Boyuan Phar­ma­ceu­ti­cal Co., whose ex­ports to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times